Behavioral Effects of a Novel Benzofuranyl-Piperazine Serotonin-2C Receptor Agonist Suggest a Potential Therapeutic Application in the Treatment of Obsessive–Compulsive Disorder
Selective serotonin reuptake inhibitors (SSRIs) are the only effective pharmacological treatments for obsessive–compulsive disorder (OCD). Nonetheless, their generally limited efficacy, side-effects, and delayed onset of action require improved medications for this highly prevalent disorder. Preclin...
Main Authors: | Michelle M. Rodriguez, Carl Overshiner, J. David Leander, Xia Li, Denise Morrow, Richard G. Conway, David L. Nelson, Karin Briner, Jeffrey M. Witkin |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2017-05-01
|
Series: | Frontiers in Psychiatry |
Subjects: | |
Online Access: | http://journal.frontiersin.org/article/10.3389/fpsyt.2017.00089/full |
Similar Items
-
Converging neurobiological evidence in primary polydipsia resembling obsessive-compulsive disorder
by: Karthick Subramanian, et al.
Published: (2017-01-01) -
Comparing the Effects of Clomipramine and Fluoxetine on Fasting Blood Glucose in Children With Obsessive-Compulsive Disorder
by: Reza Torkzaban, et al.
Published: (2006-04-01) -
Prevalence of obsessive-compulsive spectrum disorders in obsessive-compulsive disorder
by: Mohammad Aleem Siddiqui, et al.
Published: (2018-01-01) -
Effectiveness of cognitive behavioral therapy and fluoxetine on sexual function of women with obsessive compulsive disorder: A double-blind randomized controlled trial
by: Zahra Sabetnejad, et al.
Published: (2016-11-01) -
Understanding obsessive-compulsive disorder - literature review
by: Laura Piasek, et al.
Published: (2023-08-01)